| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | follicle-stimulating hormone receptor binding | 7.33e-07 | 3 | 181 | 3 | GO:0031762 | |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 8.17e-05 | 2 | 181 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | alpha-1A adrenergic receptor binding | 8.17e-05 | 2 | 181 | 2 | GO:0031691 | |
| GeneOntologyMolecularFunction | rRNA (cytosine-N4-)-methyltransferase activity | 8.17e-05 | 2 | 181 | 2 | GO:0071424 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.01e-04 | 118 | 181 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 1.52e-04 | 12 | 181 | 3 | GO:1990817 | |
| GeneOntologyMolecularFunction | alpha-1B adrenergic receptor binding | 2.44e-04 | 3 | 181 | 2 | GO:0031692 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 ERCC2 EP400 MYO7B MYO9B ANXA5 DHX57 CHD2 KIF3A DDX6 DNAH1 KIF13A ATP2A1 DNAH6 SLC27A2 | 4.92e-04 | 614 | 181 | 15 | GO:0140657 |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 2.25e-04 | 3 | 182 | 2 | GO:0048269 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 2.36e-04 | 35 | 182 | 4 | GO:0099243 | |
| GeneOntologyCellularComponent | cytoplasmic region | PCLO GRIK3 MADD KIF3A DNAH1 STXBP1 SPAG16 DNAAF1 DNAH6 PHLDB2 CFAP46 | 3.30e-04 | 360 | 182 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | calcium channel complex | 4.41e-04 | 73 | 182 | 5 | GO:0034704 | |
| Domain | MADS_MEF2-like | 7.98e-09 | 4 | 178 | 4 | IPR033896 | |
| Domain | MADS_BOX_1 | 1.18e-07 | 6 | 178 | 4 | PS00350 | |
| Domain | MADS | 1.18e-07 | 6 | 178 | 4 | SM00432 | |
| Domain | SRF-TF | 1.18e-07 | 6 | 178 | 4 | PF00319 | |
| Domain | MADS_BOX_2 | 1.18e-07 | 6 | 178 | 4 | PS50066 | |
| Domain | TF_MADSbox | 2.73e-07 | 7 | 178 | 4 | IPR002100 | |
| Domain | HJURP_C | 3.38e-06 | 4 | 178 | 3 | IPR022102 | |
| Domain | HJURP_C | 3.38e-06 | 4 | 178 | 3 | PF12347 | |
| Domain | ARM-type_fold | DOCK9 UBR4 VEPH1 NOC3L APC HUWE1 ARMCX5 RYR3 AP4E1 PI4KA INTS4 PRKDC XPO7 | 2.32e-05 | 339 | 178 | 13 | IPR016024 |
| Domain | EF_assoc_2 | 9.03e-05 | 2 | 178 | 2 | PF08356 | |
| Domain | EF_assoc_1 | 9.03e-05 | 2 | 178 | 2 | PF08355 | |
| Domain | S-AdoMet_synt_N | 9.03e-05 | 2 | 178 | 2 | PF00438 | |
| Domain | MIRO_dom | 9.03e-05 | 2 | 178 | 2 | IPR020860 | |
| Domain | MIRO | 9.03e-05 | 2 | 178 | 2 | PS51423 | |
| Domain | S-AdoMet_synthetase | 9.03e-05 | 2 | 178 | 2 | IPR002133 | |
| Domain | Mt_Rho_GTPase | 9.03e-05 | 2 | 178 | 2 | IPR021181 | |
| Domain | EF_hand_assoc_2 | 9.03e-05 | 2 | 178 | 2 | IPR013567 | |
| Domain | EF_hand_assoc_1 | 9.03e-05 | 2 | 178 | 2 | IPR013566 | |
| Domain | S-AdoMet_synt_M | 9.03e-05 | 2 | 178 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 9.03e-05 | 2 | 178 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_CS | 9.03e-05 | 2 | 178 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 9.03e-05 | 2 | 178 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 9.03e-05 | 2 | 178 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_central | 9.03e-05 | 2 | 178 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 9.03e-05 | 2 | 178 | 2 | IPR022628 | |
| Domain | ADOMET_SYNTHASE_1 | 9.03e-05 | 2 | 178 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 9.03e-05 | 2 | 178 | 2 | PS00377 | |
| Domain | NTP_transf_2 | 1.33e-04 | 11 | 178 | 3 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 1.33e-04 | 11 | 178 | 3 | IPR002934 | |
| Domain | MIRO-like | 2.27e-04 | 13 | 178 | 3 | IPR013684 | |
| Domain | Roc | 2.27e-04 | 13 | 178 | 3 | PF08477 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.32e-04 | 35 | 178 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.57e-04 | 38 | 178 | 4 | PS00690 | |
| Domain | Tox-GHH_dom | 5.35e-04 | 4 | 178 | 2 | IPR028916 | |
| Domain | Arrestin_N | 5.35e-04 | 4 | 178 | 2 | IPR014753 | |
| Domain | Tox-GHH | 5.35e-04 | 4 | 178 | 2 | PF15636 | |
| Domain | Arrestin_CS | 5.35e-04 | 4 | 178 | 2 | IPR017864 | |
| Domain | ARRESTINS | 5.35e-04 | 4 | 178 | 2 | PS00295 | |
| Domain | Arrestin | 5.35e-04 | 4 | 178 | 2 | IPR000698 | |
| Domain | Ten_N | 5.35e-04 | 4 | 178 | 2 | IPR009471 | |
| Domain | - | 5.35e-04 | 4 | 178 | 2 | 2.60.40.840 | |
| Domain | Ten_N | 5.35e-04 | 4 | 178 | 2 | PF06484 | |
| Domain | TENEURIN_N | 5.35e-04 | 4 | 178 | 2 | PS51361 | |
| Domain | YD | 8.86e-04 | 5 | 178 | 2 | IPR006530 | |
| Domain | FERM_M | 9.52e-04 | 46 | 178 | 4 | PF00373 | |
| Domain | - | 1.21e-03 | 49 | 178 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 1.21e-03 | 49 | 178 | 4 | IPR019748 | |
| Domain | FERM_domain | 1.21e-03 | 49 | 178 | 4 | IPR000299 | |
| Domain | P-loop_NTPase | MYH9 ERCC2 EP400 MYO7B MFHAS1 MYO9B DHX57 CHD2 RHOT2 PFKFB1 SLFN5 KIF3A DDX6 DNAH1 DAP3 KIF13A DNAH6 RHOT1 | 1.26e-03 | 848 | 178 | 18 | IPR027417 |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.30e-03 | 50 | 178 | 4 | IPR014352 | |
| Domain | FERM_1 | 1.30e-03 | 50 | 178 | 4 | PS00660 | |
| Domain | FERM_2 | 1.30e-03 | 50 | 178 | 4 | PS00661 | |
| Domain | FERM_3 | 1.30e-03 | 50 | 178 | 4 | PS50057 | |
| Domain | Band_41_domain | 1.30e-03 | 50 | 178 | 4 | IPR019749 | |
| Domain | B41 | 1.30e-03 | 50 | 178 | 4 | SM00295 | |
| Domain | TFR_dimer | 1.32e-03 | 6 | 178 | 2 | PF04253 | |
| Domain | - | 1.32e-03 | 6 | 178 | 2 | 1.20.930.40 | |
| Domain | TFR-like_dimer_dom | 1.84e-03 | 7 | 178 | 2 | IPR007365 | |
| Domain | - | 1.84e-03 | 7 | 178 | 2 | 2.60.40.640 | |
| Domain | E-NPP | 1.84e-03 | 7 | 178 | 2 | IPR024873 | |
| Domain | PAP_assoc | 1.84e-03 | 7 | 178 | 2 | PF03828 | |
| Domain | PAP_assoc | 1.84e-03 | 7 | 178 | 2 | IPR002058 | |
| Domain | IPT | 2.10e-03 | 27 | 178 | 3 | SM00429 | |
| Domain | Arrestin_C | 2.44e-03 | 8 | 178 | 2 | IPR014752 | |
| Domain | MYTH4 | 3.11e-03 | 9 | 178 | 2 | PS51016 | |
| Domain | MyTH4 | 3.11e-03 | 9 | 178 | 2 | SM00139 | |
| Domain | MyTH4_dom | 3.11e-03 | 9 | 178 | 2 | IPR000857 | |
| Domain | MyTH4 | 3.11e-03 | 9 | 178 | 2 | PF00784 | |
| Domain | TIG | 3.14e-03 | 31 | 178 | 3 | PF01833 | |
| Domain | Ig_E-set | 3.20e-03 | 104 | 178 | 5 | IPR014756 | |
| Domain | LRR | 3.20e-03 | 201 | 178 | 7 | PS51450 | |
| Domain | IPT | 3.45e-03 | 32 | 178 | 3 | IPR002909 | |
| Domain | Arrestin-like_N | 3.87e-03 | 10 | 178 | 2 | IPR011021 | |
| Domain | Arrestin_C-like | 3.87e-03 | 10 | 178 | 2 | IPR011022 | |
| Domain | Arrestin_C | 3.87e-03 | 10 | 178 | 2 | SM01017 | |
| Domain | Phosphodiest/P_Trfase | 3.87e-03 | 10 | 178 | 2 | IPR002591 | |
| Domain | MKP | 3.87e-03 | 10 | 178 | 2 | IPR008343 | |
| Domain | Phosphodiest | 3.87e-03 | 10 | 178 | 2 | PF01663 | |
| Domain | Arrestin_C | 3.87e-03 | 10 | 178 | 2 | PF02752 | |
| Domain | Arrestin_N | 3.87e-03 | 10 | 178 | 2 | PF00339 | |
| Domain | ARM-like | 4.44e-03 | 270 | 178 | 8 | IPR011989 | |
| Domain | Peptidase_M28 | 5.60e-03 | 12 | 178 | 2 | PF04389 | |
| Domain | Peptidase_M28 | 5.60e-03 | 12 | 178 | 2 | IPR007484 | |
| Domain | Myosin_head_motor_dom | 5.62e-03 | 38 | 178 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.62e-03 | 38 | 178 | 3 | PS51456 | |
| Domain | Myosin_head | 5.62e-03 | 38 | 178 | 3 | PF00063 | |
| Domain | MYSc | 5.62e-03 | 38 | 178 | 3 | SM00242 | |
| Domain | - | 6.05e-03 | 39 | 178 | 3 | 2.120.10.30 | |
| Domain | NHL | 6.58e-03 | 13 | 178 | 2 | PS51125 | |
| Domain | IQ | 7.51e-03 | 81 | 178 | 4 | SM00015 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.62e-03 | 14 | 178 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.62e-03 | 14 | 178 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.62e-03 | 14 | 178 | 2 | IPR013602 | |
| Domain | DHC_N2 | 7.62e-03 | 14 | 178 | 2 | PF08393 | |
| Domain | - | 7.62e-03 | 14 | 178 | 2 | 3.10.20.30 | |
| Domain | ATPase_dyneun-rel_AAA | 7.62e-03 | 14 | 178 | 2 | IPR011704 | |
| Domain | Beta-grasp_dom | 7.62e-03 | 14 | 178 | 2 | IPR012675 | |
| Domain | MT | 7.62e-03 | 14 | 178 | 2 | PF12777 | |
| Domain | AAA_8 | 7.62e-03 | 14 | 178 | 2 | PF12780 | |
| Domain | AAA_5 | 7.62e-03 | 14 | 178 | 2 | PF07728 | |
| Pubmed | 7.42e-10 | 4 | 183 | 4 | 8575763 | ||
| Pubmed | 7.42e-10 | 4 | 183 | 4 | 10207130 | ||
| Pubmed | 7.42e-10 | 4 | 183 | 4 | 21531906 | ||
| Pubmed | 7.42e-10 | 4 | 183 | 4 | 25416778 | ||
| Pubmed | 7.42e-10 | 4 | 183 | 4 | 22764880 | ||
| Pubmed | Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. | 7.42e-10 | 4 | 183 | 4 | 7643214 | |
| Pubmed | The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. | 3.69e-09 | 5 | 183 | 4 | 7646512 | |
| Pubmed | Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. | 3.69e-09 | 5 | 183 | 4 | 19093215 | |
| Pubmed | Regulatory role of MEF2D in serum induction of the c-jun promoter. | 3.69e-09 | 5 | 183 | 4 | 7760790 | |
| Pubmed | 3.69e-09 | 5 | 183 | 4 | 8993831 | ||
| Pubmed | Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. | 3.69e-09 | 5 | 183 | 4 | 12694204 | |
| Pubmed | 3.69e-09 | 5 | 183 | 4 | 10458488 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NR2C2 MEF2B NUP85 EP400 MYO9B UBR4 DEPDC1 SIN3A HUWE1 SIX4 MEF2A MEF2C MEF2D DARS2 FASN CCDC59 PI4KA FBXO42 QSER1 NUP160 XPO7 | 5.95e-09 | 857 | 183 | 21 | 25609649 |
| Pubmed | The expression of MEF2 genes is implicated in CNS neuronal differentiation. | 1.10e-08 | 6 | 183 | 4 | 9013788 | |
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 5.11e-08 | 8 | 183 | 4 | 30205047 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | USP36 MYH9 EP400 MYO9B MAT2A ANXA5 UBR4 NOC3L EIF3E DHX57 CHD2 XPC RHOT2 HUWE1 NDUFS1 DDX6 RING1 KAT7 FASN ARRB2 PI4KA PLCG1 PRKDC NUP160 PHLDB2 | 5.25e-08 | 1353 | 183 | 25 | 29467282 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERCC2 NUP85 EP400 MFHAS1 MYO9B DOCK9 DUSP5 UBR4 RHOT2 ATG2A HUWE1 PLXNB2 ITGB4 TUBG1 ACOX3 MADD MST1R FASN PI4KA PLCG1 PRKDC RBM38 | 9.99e-08 | 1105 | 183 | 22 | 35748872 |
| Pubmed | MAT2A ANXA5 UBR4 DHX57 SIN3A HUWE1 TUBG1 MRPL39 DAP3 FASN PRKDC | 1.15e-07 | 253 | 183 | 11 | 29911972 | |
| Pubmed | Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling. | 1.43e-07 | 3 | 183 | 3 | 22315403 | |
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 1.43e-07 | 3 | 183 | 3 | 22496871 | |
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 15834131 | ||
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 1.43e-07 | 3 | 183 | 3 | 18093911 | |
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 27989458 | ||
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 26286136 | ||
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 33315889 | ||
| Pubmed | 1.52e-07 | 10 | 183 | 4 | 30276662 | ||
| Pubmed | Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. | 2.38e-07 | 11 | 183 | 4 | 9162005 | |
| Pubmed | TLK2 SHLD2 AOC1 DOCK9 APC CHD2 DEPDC1 RHOT2 HUWE1 ITGB4 MADD KAT7 TTBK2 PTPN13 PAPOLA PI4KA FECH MASTL PLCG1 QSER1 KIF13A | 3.12e-07 | 1084 | 183 | 21 | 11544199 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOLH1 SPTB SHB PON2 CHD2 PFKFB1 ZSWIM6 HUWE1 GRHL2 MEF2A DNAH1 FARP2 PTPN13 ARRB1 ARRB2 FBXO42 FECH KYAT3 PLCG1 GREB1 QSER1 HPS5 CATSPERG METTL15 XPO7 | 3.19e-07 | 1489 | 183 | 25 | 28611215 |
| Pubmed | Beta-arrestin-mediated localization of smoothened to the primary cilium. | 5.71e-07 | 4 | 183 | 3 | 18497258 | |
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 31420455 | ||
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 8817457 | ||
| Pubmed | Requirement of MEF2A, C, and D for skeletal muscle regeneration. | 5.71e-07 | 4 | 183 | 3 | 24591619 | |
| Pubmed | SPAG1 MYH9 NUP85 PCLO UBR4 SHB NOC3L DHX57 CHD2 XPC NDUFS1 RING1 DAP3 FASN ARRB1 STXBP1 SACS PKHD1 TENM1 DLEC1 PRKDC ATP2A1 DNAH6 CFAP46 | 6.56e-07 | 1442 | 183 | 24 | 35575683 | |
| Pubmed | Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome. | 6.85e-07 | 32 | 183 | 5 | 20056645 | |
| Pubmed | 7.13e-07 | 14 | 183 | 4 | 12130539 | ||
| Pubmed | Control of the SOST bone enhancer by PTH using MEF2 transcription factors. | 1.42e-06 | 5 | 183 | 3 | 17696759 | |
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 15084602 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 20833138 | ||
| Pubmed | MEF2 transcription factors are key regulators of sprouting angiogenesis. | 1.42e-06 | 5 | 183 | 3 | 27898394 | |
| Pubmed | Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. | 1.42e-06 | 5 | 183 | 3 | 9753748 | |
| Pubmed | Regulation of the MEF2 family of transcription factors by p38. | 1.42e-06 | 5 | 183 | 3 | 9858528 | |
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 23511190 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 8900141 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 16504037 | ||
| Pubmed | EP400 PCLO UBR4 XPC SIN3A HUWE1 TUBG1 RING1 KAT7 NT5DC2 FECH PRKDC | 1.43e-06 | 396 | 183 | 12 | 26687479 | |
| Pubmed | MEF2C transcription factor controls chondrocyte hypertrophy and bone development. | 1.67e-06 | 17 | 183 | 4 | 17336904 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NR2C2 MYH9 ERCC2 NUP85 EP400 MAT2A UBR4 NOC3L EIF3E CHD2 HUWE1 NDUFS1 TUBG1 DARS2 DDX6 MRPL39 DAP3 FASN NT5DC2 FECH PRKDC NUP160 | 1.90e-06 | 1318 | 183 | 22 | 30463901 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | USP36 NR2C2 TENT4B NUP85 EP400 NOC3L XPC TUBA8 STXBP1 PI4KA QSER1 VPS53 | 2.05e-06 | 410 | 183 | 12 | 26949251 |
| Pubmed | 2.83e-06 | 6 | 183 | 3 | 20399744 | ||
| Pubmed | 2.83e-06 | 6 | 183 | 3 | 10737771 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TLK2 PLK2 NUP85 ANXA5 EIF3E APC XPC HAUS2 TUBG1 DDX6 NBAS TTBK2 FASN ARRB1 ARRB2 CDC16 FECH MASTL PRKDC NUP160 | 3.35e-06 | 1155 | 183 | 20 | 20360068 |
| Pubmed | TET2 PLK2 CORO2A FOLH1 ENPP2 MAT2A SPTB UBR4 APC XPC HUWE1 RYR3 MADD KIF3A GORASP2 PTPN13 ARRB1 STXBP1 SACS PLCG1 PRKDC | 4.60e-06 | 1285 | 183 | 21 | 35914814 | |
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 18848351 | ||
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 12861002 | ||
| Pubmed | Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. | 4.94e-06 | 7 | 183 | 3 | 8026334 | |
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 9129019 | ||
| Pubmed | NUP85 MAT2A EIF3E PON2 FBXW2 RHOT2 HUWE1 PLXNB2 NDUFS1 TUBG1 DDX6 FASN FECH PRKDC | 5.13e-06 | 613 | 183 | 14 | 22268729 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ERCC2 UBR4 RHOT2 SIN3A HUWE1 DARS2 DDX6 DAP3 NBAS FASN STXBP1 PLCG1 PRKDC NUP160 RHOT1 | 5.40e-06 | 704 | 183 | 15 | 29955894 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | USP36 MYH9 TENT4B MAT2A ANXA5 PCLO UBR4 NOC3L EIF3E HUWE1 NDUFS1 DARS2 CRKL DDX6 DAP3 FASN NT5DC2 PI4KA CDC16 PLCG1 PRKDC NUP160 | 6.61e-06 | 1425 | 183 | 22 | 30948266 |
| Pubmed | MYH9 ERCC2 EP400 MAT2A ANXA5 UBR4 CHD2 SIN3A CRK RING1 KAT7 FASN PAPOLA CDC16 PRKDC QSER1 KYNU XPO7 | 7.62e-06 | 1014 | 183 | 18 | 32416067 | |
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | LRRIQ3 FNTA SHB CHAD SLC35G2 ARMCX5 ACOX3 RYR3 FECH FLRT3 DNAAF1 CATSPERG ATP2A1 DNAH6 ZNF654 RBM38 SLC27A2 | 7.67e-06 | 915 | 183 | 17 | 32393512 |
| Pubmed | 7.87e-06 | 8 | 183 | 3 | 16043483 | ||
| Pubmed | 7.87e-06 | 8 | 183 | 3 | 8653787 | ||
| Pubmed | 7.87e-06 | 8 | 183 | 3 | 18957220 | ||
| Pubmed | 7.87e-06 | 8 | 183 | 3 | 11784029 | ||
| Pubmed | Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. | 7.87e-06 | 8 | 183 | 3 | 17786239 | |
| Pubmed | NUP85 FNTA MAT2A PBDC1 EIF3E DHX57 DEPDC1 HUWE1 NDUFS1 TUBG1 DARS2 CRKL DDX6 RING1 MRPL39 DAP3 FASN NT5DC2 CDC16 PRKDC NUP160 | 8.21e-06 | 1335 | 183 | 21 | 29229926 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EP400 NOC3L EIF3E CHD2 XPC SIN3A TUBG1 RING1 KAT7 CDC16 PRKDC | 8.58e-06 | 394 | 183 | 11 | 27248496 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH9 MAT2A ANXA5 UBR4 EIF3E HUWE1 TUBA8 ITGB4 NDUFS1 DAP3 TTBK2 FASN PRKDC ATP2A1 | 9.43e-06 | 647 | 183 | 14 | 26618866 |
| Pubmed | 9.79e-06 | 195 | 183 | 8 | 19454010 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PLK2 ERCC2 EIF3E ATG2A HAUS2 MEF2A MEF2D TUBG1 MADD DDX6 RING1 FARP2 AP4E1 KAT7 GORASP2 ARRB2 TBC1D12 IL33 | 1.04e-05 | 1038 | 183 | 18 | 26673895 |
| Pubmed | 1.08e-05 | 94 | 183 | 6 | 32062451 | ||
| Pubmed | 1.18e-05 | 9 | 183 | 3 | 9738004 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.26e-05 | 202 | 183 | 8 | 33005030 | |
| Pubmed | 1.36e-05 | 268 | 183 | 9 | 33640491 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.46e-05 | 341 | 183 | 10 | 32971831 | |
| Pubmed | 1.49e-05 | 418 | 183 | 11 | 34709266 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.57e-05 | 344 | 183 | 10 | 30333137 | |
| Pubmed | MYH9 APC HUWE1 ITGB4 MEF2D KAT7 FASN GORASP2 CDC16 MASTL KIF13A PHLDB2 | 1.61e-05 | 503 | 183 | 12 | 16964243 | |
| Pubmed | 1.67e-05 | 10 | 183 | 3 | 38713721 | ||
| Pubmed | Implication of geranylgeranyltransferase I in synapse formation. | 1.67e-05 | 10 | 183 | 3 | 14622576 | |
| Pubmed | Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons. | 1.67e-05 | 10 | 183 | 3 | 15062102 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | NUP85 FNTA MAT2A DUSP1 DUSP5 UBR4 PON2 HUWE1 SIX4 CRKL MRPL39 FASN NT5DC2 PLCG1 PRKDC ATP2A1 NUP160 | 1.71e-05 | 974 | 183 | 17 | 28675297 |
| Pubmed | 2.29e-05 | 11 | 183 | 3 | 22569362 | ||
| Pubmed | 2.29e-05 | 11 | 183 | 3 | 33627187 | ||
| Pubmed | 2.38e-05 | 32 | 183 | 4 | 21768366 | ||
| Pubmed | 2.38e-05 | 32 | 183 | 4 | 20111592 | ||
| Pubmed | Mef2d is essential for the maturation and integrity of retinal photoreceptor and bipolar cells. | 2.38e-05 | 32 | 183 | 4 | 25757744 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH9 ANXA5 PCLO UBR4 EIF3E HUWE1 DDX6 EPG5 DNAH1 NBAS FASN MASTL PRKDC ATP2A1 KYNU | 2.67e-05 | 807 | 183 | 15 | 30575818 |
| Pubmed | Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway. | 2.75e-05 | 2 | 183 | 2 | 19074029 | |
| Pubmed | Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. | 2.75e-05 | 2 | 183 | 2 | 22569336 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19027756 | ||
| Pubmed | Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. | 2.75e-05 | 2 | 183 | 2 | 19098100 | |
| Pubmed | Physiological signals and oncogenesis mediated through Crk family adapter proteins. | 2.75e-05 | 2 | 183 | 2 | 10092207 | |
| Pubmed | Mitochondrial trafficking in neurons and the role of the Miro family of GTPase proteins. | 2.75e-05 | 2 | 183 | 2 | 24256248 | |
| Pubmed | ARRB2 (β-Arrestin-2) Deficiency Alters Fluid Homeostasis and Blood Pressure Regulation. | 2.75e-05 | 2 | 183 | 2 | 36215165 | |
| Pubmed | Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. | 2.75e-05 | 2 | 183 | 2 | 17618287 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 35122963 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 9668034 | ||
| Interaction | BOP1 interactions | USP36 NR2C2 MYH9 DUSP5 NOC3L CASQ2 HUWE1 MST1R GORASP2 ARRB1 ARRB2 | 1.22e-06 | 191 | 180 | 11 | int:BOP1 |
| Interaction | MEF2B interactions | 1.93e-06 | 11 | 180 | 4 | int:MEF2B | |
| Interaction | BORCS8-MEF2B interactions | 7.78e-06 | 15 | 180 | 4 | int:BORCS8-MEF2B | |
| Cytoband | 2p22.1 | 3.36e-05 | 16 | 183 | 3 | 2p22.1 | |
| Cytoband | 15q26 | 3.36e-05 | 16 | 183 | 3 | 15q26 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 2.11e-09 | 4 | 124 | 4 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.05e-08 | 5 | 124 | 4 | 1086 | |
| GeneFamily | Miro like atypical Rho GTPases|EF-hand domain containing | 4.67e-05 | 2 | 124 | 2 | 392 | |
| GeneFamily | Classical arrestins | 2.77e-04 | 4 | 124 | 2 | 1312 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.80e-04 | 50 | 124 | 4 | 1293 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.50e-04 | 206 | 124 | 7 | 682 | |
| GeneFamily | Non-canonical poly(A) polymerases | 9.58e-04 | 7 | 124 | 2 | 1318 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 1.27e-03 | 8 | 124 | 2 | 1125 | |
| GeneFamily | MAP kinase phosphatases | 2.46e-03 | 11 | 124 | 2 | 895 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | GPR18 TENT4B DUSP1 DUSP5 ENPP4 MEF2D EPG5 KAT7 CCDC59 PDP1 RBM38 | 4.16e-06 | 276 | 183 | 11 | M41128 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_669C_3P_GENES | 5.93e-06 | 183 | 183 | 9 | MM17506 | |
| Coexpression | HALLMARK_MYOGENESIS | 1.21e-05 | 200 | 183 | 9 | M5909 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP | 1.21e-05 | 200 | 183 | 9 | M7872 | |
| Coexpression | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A | 1.25e-05 | 21 | 183 | 4 | M1501 | |
| Coexpression | FRASOR_RESPONSE_TO_ESTRADIOL_DN | 1.81e-05 | 78 | 183 | 6 | M3002 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.93e-05 | 212 | 183 | 9 | M39221 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ENPP2 MAT2A MGAT4A NOC3L APC ENPP4 TRAPPC8 MEF2A MEF2C RYR3 DDX6 DAP3 CCDC59 PAPOLA SACS PI4KA CDC16 FECH KYAT3 PRKDC NUP160 RHOT1 | 4.26e-05 | 1215 | 183 | 22 | M41122 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP | 5.75e-05 | 189 | 183 | 8 | M9978 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | EPOR PLK2 MYH9 CORO2A DUSP1 MGAT4A ACOX3 KIF3A LPCAT2 PDP1 KYNU ZNF654 PHLDB2 | 5.81e-05 | 504 | 183 | 13 | M2157 |
| Coexpression | GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP | 6.49e-05 | 142 | 183 | 7 | M7971 | |
| Coexpression | GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 7.97e-05 | 198 | 183 | 8 | M3324 | |
| Coexpression | GSE25087_TREG_VS_TCONV_ADULT_UP | 8.25e-05 | 199 | 183 | 8 | M4650 | |
| Coexpression | GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 8.25e-05 | 199 | 183 | 8 | M5357 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 8.54e-05 | 200 | 183 | 8 | M3277 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN | 8.54e-05 | 200 | 183 | 8 | M8966 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 8.54e-05 | 200 | 183 | 8 | M9136 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | SPAG1 MAT1A ENPP4 KIF3A DNAH1 PLCB2 DLEC1 DNAAF1 DNAH6 RBM38 CFAP46 SLC27A2 | 9.90e-05 | 459 | 183 | 12 | M39136 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYH9 EP400 FNTA MYO9B DUSP1 DOCK9 MGAT4A UBR4 FBXW2 CHD2 SIN3A SLFN5 HUWE1 TRAPPC8 MEF2D DDX6 EPG5 ARRB2 PAPOLA SACS CDC16 PLCB2 PLCG1 RBM38 | 1.19e-04 | 1492 | 183 | 24 | M40023 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-09 | 184 | 183 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-09 | 184 | 183 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-09 | 184 | 183 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.62e-07 | 181 | 183 | 8 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-07 | 183 | 183 | 8 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-06 | 194 | 183 | 8 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.63e-06 | 197 | 183 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.82e-06 | 200 | 183 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-06 | 156 | 183 | 7 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-06 | 159 | 183 | 7 | 0a3a363b30a8c741e1a3e2525725108d03c21776 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-06 | 159 | 183 | 7 | 299e2162a82e31196d7f3a110c2db622349edfff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 169 | 183 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.16e-06 | 175 | 183 | 7 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.79e-06 | 177 | 183 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 178 | 183 | 7 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.80e-06 | 180 | 183 | 7 | 708a5c89b9337e281fce4f482892a1c1766c7812 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.80e-06 | 180 | 183 | 7 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 181 | 183 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 182 | 183 | 7 | fea094fe0e7796c084e60b5310c1559658633f7a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 183 | 183 | 7 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 186 | 183 | 7 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 186 | 183 | 7 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 186 | 183 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 186 | 183 | 7 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-05 | 187 | 183 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.26e-05 | 187 | 183 | 7 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-05 | 189 | 183 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-05 | 189 | 183 | 7 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.39e-05 | 190 | 183 | 7 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.54e-05 | 193 | 183 | 7 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.59e-05 | 194 | 183 | 7 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.65e-05 | 195 | 183 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.65e-05 | 195 | 183 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.70e-05 | 196 | 183 | 7 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.70e-05 | 196 | 183 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-05 | 197 | 183 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-05 | 197 | 183 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-05 | 197 | 183 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-05 | 197 | 183 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 197 | 183 | 7 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.82e-05 | 198 | 183 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 198 | 183 | 7 | 58508a8df2714d769f137794c29441a7bd38b350 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 198 | 183 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Endothelial_cells-Endothelial-A|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.88e-05 | 199 | 183 | 7 | 2a1424c61ddcd1fea9574f7a3ad1955387458130 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-intermediate_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 199 | 183 | 7 | f9e3fb974ba8fe1b6d99892577549ef143df9e08 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.88e-05 | 199 | 183 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.94e-05 | 200 | 183 | 7 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 183 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 183 | 7 | fdf3e60cf94f398a56c0fa72813d0459f5ce081b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 183 | 7 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 183 | 7 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Erythrocytes|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.94e-05 | 200 | 183 | 7 | a9edac2f5e009662df452ec032a80e855cdac28f | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 183 | 7 | b5f2892bc45fda5ae05e269b840305a608a07c37 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 183 | 7 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 183 | 7 | 9ce1f91991637fc3af0f6a80a85e1a44276fe412 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 183 | 7 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-05 | 200 | 183 | 7 | 199165be1aef8497af71b74690a11de18fbe073c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 183 | 7 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 3.81e-05 | 151 | 183 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 154 | 183 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.25e-05 | 154 | 183 | 6 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 154 | 183 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 154 | 183 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 154 | 183 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 155 | 183 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 155 | 183 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 4.57e-05 | 156 | 183 | 6 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 160 | 183 | 6 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 160 | 183 | 6 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.45e-05 | 161 | 183 | 6 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 100 | 183 | 5 | ea36e4ff513d66186b92e39c549e55c26609cb30 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 100 | 183 | 5 | ceca7d9342e5ee7293f07edb815beee4eb010fe7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 164 | 183 | 6 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.24e-05 | 165 | 183 | 6 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.24e-05 | 165 | 183 | 6 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.68e-05 | 167 | 183 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.90e-05 | 168 | 183 | 6 | b220e732eb7b204fc263a9f2e8ddae6bf9fa98f4 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 168 | 183 | 6 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | Substantia_nigra-Endothelial-MURAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.90e-05 | 168 | 183 | 6 | 271a81c59a9a75bac6107c68fead03e7f35bc192 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.32e-05 | 105 | 183 | 5 | 76b73bc9236030e0703868fa8f7ecee2affe565b | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.32e-05 | 105 | 183 | 5 | 96566c83999aa625c84a4ed18a6df9daa99f9578 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.32e-05 | 105 | 183 | 5 | bfd3395c51a0e868aa92eac4e929de59a3fe8b50 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.37e-05 | 170 | 183 | 6 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-05 | 172 | 183 | 6 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.37e-05 | 174 | 183 | 6 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 175 | 183 | 6 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-05 | 178 | 183 | 6 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.49e-05 | 178 | 183 | 6 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-05 | 178 | 183 | 6 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.49e-05 | 178 | 183 | 6 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.49e-05 | 178 | 183 | 6 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-05 | 178 | 183 | 6 | eafacc8cd3e986d6ca309e05b6e241331a584fa5 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.49e-05 | 178 | 183 | 6 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 9.49e-05 | 178 | 183 | 6 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-05 | 178 | 183 | 6 | 6a5c31e976852edc7d9e899da8e2a1bf23d36759 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-05 | 178 | 183 | 6 | 370749834a11d981e9ede26d5f63f0ecb551c015 | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.83e-06 | 195 | 181 | 10 | 2855_UP | |
| Drug | pyrophosphate | ACP6 MYH9 ERCC2 TENT4A MYO9B MAT1A ENPP2 MAT2A PFKFB1 DARS2 ACOX3 FARP2 PAPOLA CDC16 PLCB2 PLCG1 SLC38A3 SLC27A2 | 5.11e-06 | 654 | 181 | 18 | CID000001023 |
| Drug | mercury orange | 9.71e-06 | 6 | 181 | 3 | CID005359843 | |
| Drug | guanine | IGFN1 TENT4A MYO9B DOCK9 APC XPC RHOT2 TUBA8 TUBG1 CRK MADD CRKL MST1R DAP3 ARRB1 ARRB2 PLCB2 PLCG1 SLC38A3 RHOT1 XPO7 | 1.07e-05 | 902 | 181 | 21 | CID000000764 |
| Disease | intellectual disability (implicated_via_orthology) | 1.00e-04 | 75 | 181 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | prostate carcinoma | TET2 COL6A3 MYO9B MAT2A SIX4 FARP2 DAP3 STXBP1 PKHD1 INTS4 QSER1 PLEKHH2 FAM118A KIF13A CATSPERG VPS53 | 1.30e-04 | 891 | 181 | 16 | EFO_0001663 |
| Disease | pulse pressure measurement | USP36 TET2 COL6A3 MFHAS1 FOLH1 ENPP2 SHB CASQ2 CHD2 PLXNB2 CRK MADD SLC5A11 FASN CDC16 TBC1D12 KYAT3 DLEC1 FAM118A ENPEP NUP160 | 1.36e-04 | 1392 | 181 | 21 | EFO_0005763 |
| Disease | mean platelet volume | TET2 MYH9 AOC1 MYO9B FOLH1 SPAG7 SIN3A TUBA8 MEF2C CRKL GORASP2 PI4KA LRRC8A INTS4 CATSPERG KYNU RBM38 | 1.93e-04 | 1020 | 181 | 17 | EFO_0004584 |
| Disease | Adenocarcinoma of lung (disorder) | 2.94e-04 | 206 | 181 | 7 | C0152013 | |
| Disease | Cleft palate, cleft lip | 3.45e-04 | 279 | 181 | 8 | EFO_0003959, HP_0000175 | |
| Disease | Alzheimer disease, APOE carrier status | 3.52e-04 | 98 | 181 | 5 | EFO_0007659, MONDO_0004975 | |
| Disease | metabolic acidosis (biomarker_via_orthology) | 3.70e-04 | 5 | 181 | 2 | DOID:0050758 (biomarker_via_orthology) | |
| Disease | progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B | 3.70e-04 | 5 | 181 | 2 | EFO_0004920, EFO_0007682, EFO_0007683, EFO_1001480 | |
| Disease | 2-hydroxy-4-(methylthio)butanoic acid measurement | 3.70e-04 | 5 | 181 | 2 | EFO_0800113 | |
| Disease | Intellectual Disability | 4.67e-04 | 447 | 181 | 10 | C3714756 | |
| Disease | xeroderma pigmentosum (is_implicated_in) | 5.52e-04 | 6 | 181 | 2 | DOID:0050427 (is_implicated_in) | |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 5.52e-04 | 6 | 181 | 2 | DOID:0050427 (implicated_via_orthology) | |
| Disease | thrombocytopenia (is_implicated_in) | 5.96e-04 | 27 | 181 | 3 | DOID:1588 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 6.64e-04 | 28 | 181 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | Rectal Neoplasms | 7.70e-04 | 7 | 181 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 7.70e-04 | 7 | 181 | 2 | C0007113 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 9.08e-04 | 181 | 181 | 6 | DOID:684 (is_implicated_in) | |
| Disease | X-24748 measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0022136 | |
| Disease | Xeroderma pigmentosum | 1.31e-03 | 9 | 181 | 2 | cv:C0043346 | |
| Disease | mean reticulocyte volume | MYH9 EP400 MYO9B SPTB NOC3L PFKFB1 ENPP4 MEF2C KAT7 TBC1D12 INTS4 RBM38 XPO7 | 1.37e-03 | 799 | 181 | 13 | EFO_0010701 |
| Disease | Primary ciliary dyskinesia | 1.40e-03 | 36 | 181 | 3 | cv:C0008780 | |
| Disease | Profound Mental Retardation | 1.70e-03 | 139 | 181 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.70e-03 | 139 | 181 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.70e-03 | 139 | 181 | 5 | C0917816 | |
| Disease | colon cancer (biomarker_via_orthology) | 1.76e-03 | 39 | 181 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | lobe attachment | 1.80e-03 | 207 | 181 | 6 | EFO_0007667 | |
| Disease | Basal cell carcinoma | 1.98e-03 | 11 | 181 | 2 | C0007117 | |
| Disease | Myoclonic Astatic Epilepsy | 1.98e-03 | 11 | 181 | 2 | C0393702 | |
| Disease | hemorrhoid | 2.18e-03 | 147 | 181 | 5 | EFO_0009552 | |
| Disease | N-acetylputrescine measurement | 2.37e-03 | 12 | 181 | 2 | EFO_0800127 | |
| Disease | C-C motif chemokine 16 measurement | 2.37e-03 | 12 | 181 | 2 | EFO_0008044 | |
| Disease | Intestinal Neoplasms | 2.37e-03 | 12 | 181 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 2.37e-03 | 12 | 181 | 2 | C0346627 | |
| Disease | disks large homolog 3 measurement | 2.37e-03 | 12 | 181 | 2 | EFO_0802472 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.52e-03 | 152 | 181 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 2.79e-03 | 13 | 181 | 2 | C0750905 | |
| Disease | imidazole lactate measurement | 2.79e-03 | 13 | 181 | 2 | EFO_0800004 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 2.79e-03 | 13 | 181 | 2 | C0002514 | |
| Disease | response to bronchodilator, FEV/FEC ratio | TET2 SLC25A27 ENPP2 SLCO3A1 GRIK3 ATG2A TENM2 CRK PKHD1 DLEC1 SPAG16 DNAAF1 | 2.84e-03 | 766 | 181 | 12 | EFO_0004713, GO_0097366 |
| Disease | hypertension | 2.97e-03 | 307 | 181 | 7 | EFO_0000537 | |
| Disease | Primary Ciliary Dyskinesia | 3.02e-03 | 47 | 181 | 3 | C4551720 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.40e-03 | 49 | 181 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 3.73e-03 | 15 | 181 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 3.73e-03 | 15 | 181 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | TET2 MFHAS1 MYO9B ENPP2 DOCK9 APC PLXNB2 TENM2 MEF2C CRKL NT5DC2 FBXO42 PKHD1 DGKI QSER1 FAM118A RHOT1 | 3.91e-03 | 1345 | 181 | 17 | EFO_0010736 |
| Disease | hematocrit | SHLD2 MYH9 AOC1 MAT1A MEF2C DARS2 AP4E1 TTBK2 NT5DC2 PKHD1 ACMSD NUP160 IL33 RBM38 | 3.95e-03 | 1011 | 181 | 14 | EFO_0004348 |
| Disease | urinary metabolite measurement | 4.15e-03 | 245 | 181 | 6 | EFO_0005116 | |
| Disease | nervousness | 4.24e-03 | 16 | 181 | 2 | NCIT_C74532 | |
| Disease | Pontoneocerebellar hypoplasia | 4.24e-03 | 16 | 181 | 2 | cv:C1261175 | |
| Disease | melanoma | 4.40e-03 | 248 | 181 | 6 | C0025202 | |
| Disease | comparative body size at age 10, self-reported | 4.56e-03 | 420 | 181 | 8 | EFO_0009819 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 4.78e-03 | 335 | 181 | 7 | EFO_0009931 | |
| Disease | major depressive disorder (is_marker_for) | 4.79e-03 | 17 | 181 | 2 | DOID:1470 (is_marker_for) | |
| Disease | Familial Progressive Myoclonic Epilepsy | 4.79e-03 | 17 | 181 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 4.79e-03 | 17 | 181 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 4.79e-03 | 17 | 181 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 4.79e-03 | 17 | 181 | 2 | C0751780 | |
| Disease | May-White Syndrome | 4.79e-03 | 17 | 181 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 4.79e-03 | 17 | 181 | 2 | C0751781 | |
| Disease | Hypertrophic Cardiomyopathy | 5.21e-03 | 57 | 181 | 3 | C0007194 | |
| Disease | noggin measurement | 5.37e-03 | 18 | 181 | 2 | EFO_0021995 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 5.37e-03 | 18 | 181 | 2 | C0751779 | |
| Disease | cartilage thickness measurement | 5.37e-03 | 18 | 181 | 2 | EFO_0007873 | |
| Disease | breast cancer (is_marker_for) | 5.79e-03 | 185 | 181 | 5 | DOID:1612 (is_marker_for) | |
| Disease | prion disease | 5.97e-03 | 19 | 181 | 2 | EFO_0004720 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHFKSYSLTPDIYLI | 651 | O60347 | |
| YNTASDDLELLYHIP | 436 | Q6ZRH7 | |
| LAYFLDKSSDELPYL | 401 | P16118 | |
| PIEKYALNYLELFHT | 2161 | Q96L91 | |
| HYPPSIILAKESYAE | 2171 | Q9HCE0 | |
| PSNIDKSLYVAEYHS | 461 | P26196 | |
| HLGALDYLLPEEYTS | 106 | Q86TW2 | |
| LLPYLAAVYALDHFS | 356 | O15254 | |
| ALSKSPFIVHLYYSL | 86 | Q96GX5 | |
| SHPDEYKIAALVFYS | 16 | Q14330 | |
| YDSLSKIPYLEELHL | 121 | Q9NZU0 | |
| TYYQPRALEKHADSI | 46 | O95870 | |
| KFTEQEHPDYYLLLV | 411 | A8MVX0 | |
| IQKPTYSLYFLDHLV | 1451 | Q8IYW2 | |
| SFYTDALVHDPLSLK | 261 | Q8TDX5 | |
| LHFPSALQYTLKDEV | 421 | A6NK59 | |
| KPSRLYDAYELKHAL | 86 | P08758 | |
| RPISTAEYALLYHTL | 141 | P19801 | |
| TYLYLDHNKVTELPR | 126 | O15335 | |
| SIKFEDHYVITSYIP | 421 | Q6P1M9 | |
| PLHLEASLDKEIYYH | 196 | P49407 | |
| EASLDKELYYHGEPL | 201 | P32121 | |
| PSHKSKIVEYLQSYD | 681 | O14983 | |
| HIFLPSKEVYESIYN | 821 | Q2TAZ0 | |
| SLAYKYVIHEDLLPL | 821 | Q8WXS8 | |
| VHTVYSIYPKSELLE | 321 | Q9UPM8 | |
| SLPALLEFYKIHYLD | 96 | P46108 | |
| LPYHTTDASLRKYFE | 41 | Q9H0Z9 | |
| EYAYLKAIVLFSPDH | 491 | P49116 | |
| YALAADHTVYKLPEK | 106 | Q08257 | |
| VDPEKIQLYSLYHSL | 1661 | Q2KHR3 | |
| LLEHYYKENDPSVRL | 76 | Q96HW7 | |
| LYHTAAKIEAPALAF | 476 | Q8IWT6 | |
| YAYVVLSHAVSPIAK | 386 | Q8NDF8 | |
| LLYKAIDAYAEDHGP | 1091 | O60840 | |
| EYILSFLSPYQEHKT | 56 | Q6P3S6 | |
| YLIETLHSLIDNLYP | 151 | Q9UM21 | |
| KLFLDHKTLYYDVEP | 426 | O95251 | |
| IPKILAEESYLYKHD | 201 | Q9NVX0 | |
| LEIAQTHYYSKEPDK | 1041 | Q8WXG6 | |
| HEAKPLKLYVYNTDT | 156 | Q9H8Y8 | |
| DYIIHDPKYEDASLI | 1411 | Q4ZG55 | |
| YLHESGKLLYFEDSP | 706 | Q9Y4C4 | |
| VPAKYLDEDTIYHLQ | 231 | P31153 | |
| DSVELAHYDVLLSYP | 106 | Q04609 | |
| YSHVLAEFESLDPLL | 11 | Q9UPZ3 | |
| HPAEFLAYLDSLVKS | 886 | Q9UPZ3 | |
| ENIYSRHKIYKLSPE | 181 | P17181 | |
| ITYKFKSPDHLPDLY | 5036 | Q9Y6V0 | |
| DANETLPLHLYVKSY | 731 | O15031 | |
| ASLLTVALHGKLEYY | 1351 | O15031 | |
| PIDLHYYAQSSLDLF | 321 | Q9BW27 | |
| SELFYYAQKAVLHPT | 156 | Q8IXI2 | |
| SLHEPTYYFLSILAL | 56 | Q8NH63 | |
| HAEVYYKLISSVDPQ | 46 | Q9BVG4 | |
| HYSPGLLIEKSDAYT | 121 | Q02817 | |
| DHSYYTLIDLSPVAA | 256 | Q9Y6X5 | |
| YEQHAKSVLPKSIYD | 11 | Q9UJM8 | |
| TTASPIEYQDKLYLH | 536 | Q14D04 | |
| PSYLQTAVEKHLDYL | 686 | Q5TB30 | |
| KYAYSPSEIKEILHL | 61 | Q8WVB3 | |
| LSADIHKDQPYYDIP | 1021 | P42356 | |
| VPAKYLDEDTVYHLQ | 231 | Q00266 | |
| VYSYHYLLDPKIADL | 206 | P18074 | |
| LLKYTEYNEPHESRT | 66 | Q06413 | |
| EHLKTDLLLEPYNKY | 286 | P35579 | |
| DPTAYALAEHLSELY | 121 | P0C7V9 | |
| HYDLHVKPLLEEDTY | 101 | Q07075 | |
| LLKYTEYNEPHESRT | 66 | Q02078 | |
| LPALLEFYKIHYLDT | 81 | P46109 | |
| KDPFEVDLSHVYLAY | 641 | Q9Y496 | |
| DPTAYALAEHLSELY | 121 | A6NJ78 | |
| LPTSLKHIISNAEYY | 536 | Q7Z6Z7 | |
| FHDLKVAPGYYTLTA | 911 | P16144 | |
| PHYRVSYEKSIDLVL | 1161 | A2RRP1 | |
| YYIAVSLLPHETLLE | 161 | Q9P0J1 | |
| LLKYTEYSEPHESRT | 66 | Q02080 | |
| EKHTYYLTADSPNIL | 771 | Q8IVE3 | |
| YAYIVLSHAVSPLAR | 486 | Q5XG87 | |
| LKHPEYAKIFTTYLD | 491 | Q7L5N7 | |
| YKHYIVLLASAPTEK | 371 | P51003 | |
| SDPFLKYLETYLNLH | 186 | Q15165 | |
| EYLAELTRHNYVTPK | 2791 | Q9P2D7 | |
| YVTPKSYLELLHIFS | 2801 | Q9P2D7 | |
| LFLYSVPNKVDLEHY | 246 | Q9NWS6 | |
| YLSHKLVDLYPSNPV | 286 | Q13042 | |
| YLYHRELTKIPIFSL | 261 | Q9C0G6 | |
| KDKVLLSYYESQHPS | 156 | O95760 | |
| QYDVPSLATHSAYLK | 191 | Q6ISB3 | |
| PKDLDSKYAYIQVTH | 1856 | Q9BZ29 | |
| DKITFHPYYTIKDAL | 216 | P00156 | |
| EILPFLYLGSAYHAS | 176 | P28562 | |
| DILAEYLTIKHYPFQ | 821 | O14647 | |
| IAPYYEDSDLKDLSH | 901 | O75912 | |
| FDSPYLLYHEKIKTS | 1276 | Q6P158 | |
| HPYVLTEDTLKVYLN | 1921 | P12111 | |
| SADKPHLSYLTEYRS | 301 | Q92828 | |
| DVYKNLYSDDIPHAL | 56 | P60228 | |
| SQALHKRPKLDSEYY | 211 | Q8IV03 | |
| LHITSEDPTYTVLYL | 61 | Q8N2R8 | |
| YSILPHGVIYDKASD | 481 | Q6MZM0 | |
| KLYITPALNDTLYLH | 101 | Q8NEP3 | |
| HLKYLYLVVSDSGIS | 451 | P19235 | |
| LLCLYYHEPVSSDKV | 51 | O14958 | |
| HYDVLKPYVAVFTES | 146 | P13584 | |
| RLLHPSDKYEVYVSP | 346 | Q86VF2 | |
| EITRYYLPELSHQKS | 4111 | Q8NDH2 | |
| LLDELSPNTAPHKYY | 146 | P22830 | |
| NLYPDYASLSHAILD | 151 | Q13003 | |
| YKTHQDDYPLASLPL | 961 | O94887 | |
| AAPLDSIHSLAAYYI | 2276 | P49327 | |
| HSPGDYILLSADKYE | 286 | Q9UKT8 | |
| LRKHHLISPEDYYTD | 201 | Q9Y238 | |
| LVKSSILVFDDAPHY | 3916 | Q9NZJ4 | |
| EILPFLYLGSAYHAS | 181 | Q16690 | |
| YPEILTLKTYLHTYE | 846 | Q13822 | |
| FGHPSLVKALSYLYE | 101 | Q6YP21 | |
| LISKIYPSREEYEAH | 106 | Q06587 | |
| LLKYTEYNEPHESRT | 66 | Q14814 | |
| SYIKEELPKLHNTYV | 741 | Q12923 | |
| LLPTLYEIHSKTTAY | 241 | Q86T96 | |
| DVLNIDPLKFYTHLY | 571 | Q8WTT2 | |
| DRYVAISKPLHYATI | 121 | Q8NGI6 | |
| PALNELLVYYLKDHT | 456 | Q9H1H9 | |
| LELLHYLKNTSFAYP | 106 | P51398 | |
| SFTKDAHALIYKDLP | 201 | Q9NYK5 | |
| AHALIYKDLPFETLE | 206 | Q9NYK5 | |
| YTEPKKARSQHYDLV | 516 | Q6PI48 | |
| DSVPEVIHYYTTRKL | 476 | Q15464 | |
| ELLHTYSKVDPFDVL | 351 | Q99624 | |
| LLSALPEFLTHQYKY | 121 | Q9UIG8 | |
| VVSPASDYKDKYSHL | 156 | O75391 | |
| SELFYYAQKAVLHPT | 156 | Q8IXI1 | |
| LIGSPVDLTYTYDHL | 431 | P28331 | |
| KLIYSLPADVEHGYS | 241 | Q8NBL3 | |
| ADDVIYITLPFYHSA | 256 | O14975 | |
| YYALDKFHPALVSTV | 336 | Q8TBE7 | |
| HSSPYLIAFLVDIYE | 306 | P49354 | |
| IYPELYSILESHSFE | 161 | Q9UIU6 | |
| DLLAYVSSKHSYLRD | 556 | Q86V20 | |
| QPDIYKAFLEILHTY | 321 | Q96ST3 | |
| ERPVLVKSIHYLYFS | 511 | Q8WWX8 | |
| TDRYPDNLKHLYLAE | 86 | Q9P031 | |
| VSILELSTSPAHKYY | 1226 | Q9UKZ4 | |
| AHKYYLAVDPVSGSL | 1286 | Q9NT68 | |
| DTDLYLKSPLRYSHN | 2101 | P08F94 | |
| PLLTFSVKTHDRIYY | 1211 | Q86SQ0 | |
| EDKLDTKHYPYISTR | 491 | P61764 | |
| SSLVDHLYLLPYENL | 571 | Q12769 | |
| LDHPRIVKLYDYFSL | 521 | Q86UE8 | |
| RHVDQPIDYSLKYAT | 1171 | P25054 | |
| PKYLHYDEETSHQLL | 26 | O00300 | |
| LDYSHYISLPAGVLS | 101 | P17152 | |
| VEYDAYKLSRLPLHT | 136 | P17152 | |
| YAHGLISDYIPKELS | 211 | Q5TBB1 | |
| VYDYVRKILKLPHSS | 226 | Q9H5L6 | |
| LIDEYHAATRPDYIS | 431 | P23258 | |
| PEKLEYIVTKYAEHS | 2611 | Q15413 | |
| YPSDAISTEHAIYLA | 451 | Q9H0I9 | |
| PSLVYQHLLYLSKAE | 866 | Q07617 | |
| LKLHYASYEPTIRVL | 216 | Q8N0X2 | |
| HISSLDYFTKPDYQL | 261 | Q6IQ55 | |
| YDTVKHYLVLNTPLE | 211 | O95847 | |
| LYEHEAQHYLSKTPE | 861 | Q8IZM8 | |
| FDSLVDLISYYEKHP | 731 | P19174 | |
| APDKIRKLYLYAAHD | 321 | Q9NPH0 | |
| RKLYLYAAHDVTFIP | 326 | Q9NPH0 | |
| PDEKSIITYVVAFYH | 261 | P11277 | |
| STARDILIEHYKYPE | 91 | Q9H857 | |
| VSKCFEPHLYVYIES | 421 | Q5VIR6 | |
| IDEIFTSYHAKAKPY | 221 | Q00722 | |
| VPTYKDYVDLFRHLL | 521 | P78527 | |
| KYLFTSLLPHDAELA | 771 | Q9HCJ5 | |
| PHSDLLDYPKLSQSY | 876 | Q9UIA9 | |
| IPNTLKYYVLLHDVS | 186 | Q9Y2L5 | |
| SLLPDKKTVHYYAEL | 536 | Q9NYY3 | |
| RHLLKYEAIYPETAA | 651 | Q01831 | |
| LVIYYSLLHPKSTDI | 311 | Q6UX68 | |
| AEYLALYQKLITSAH | 4181 | Q5T4S7 | |
| THGELLEKTLSQYYP | 221 | Q6N021 | |
| SVLPKHLVSYSIEYV | 236 | Q04912 | |
| VYTPESLYKELFSQH | 386 | Q08AF3 | |
| LPSKYHGYEELLTAK | 611 | Q6P2D8 | |
| TYTPPLANYLLSKEH | 141 | Q9P275 | |
| TYAPIISAEKAYHEQ | 271 | Q9NY65 | |
| YKILLEAKAFPSDHY | 156 | Q16719 | |
| IYYPVDLKNSSEHRK | 291 | A6PVS8 | |
| DSAKLVHYDVLLSYP | 96 | Q9Y3Q0 | |
| DKQLLSLGTPSEYHY | 266 | Q6PIF6 | |
| YIHYTDNRPTLDLLA | 486 | Q6PIF6 | |
| ADTILHYHQELPKYL | 1906 | Q6PIF6 | |
| LEPHVFALADVAYYT | 211 | Q13459 |